Induced coma
|
WikiDoc Resources for Induced coma |
|
Articles |
|---|
|
Most recent articles on Induced coma Most cited articles on Induced coma |
|
Media |
|
Powerpoint slides on Induced coma |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Induced coma at Clinical Trials.gov Clinical Trials on Induced coma at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Induced coma
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Induced coma Discussion groups on Induced coma Patient Handouts on Induced coma Directions to Hospitals Treating Induced coma Risk calculators and risk factors for Induced coma
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Induced coma |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
A barbiturate-induced coma, or barb coma, is a temporary coma (a deep state of unconsciousness) brought on by a controlled dose of a barbiturate drug, usually pentobarbital or thiopental. Barbiturate comas are used to protect the brain during major surgery, and as a last line of treatment in certain cases of status epilepticus that have not responded to other treatments.
Barbiturates reduce the metabolic rate of brain tissue, as well as the cerebral blood flow. With these reductions, the blood vessels in the brain narrow, decreasing the amount of volume occupied by the brain, and hence the intra-cranial pressure. The hope is that, with the swelling relieved, the pressure decreases and some or all brain damage may be averted. Several studies have supported this theory by showing reduced mortality when treating refractory intracranial hypertension with a barbiturate coma. [1] [2] [3]
Controversy exists, however, over the benefits of using barbiturates to control intracranial hypertension. Some studies have shown that barbiturate-induced coma can reduce intracranial hypertension but does not necessarily prevent brain damage. Furthermore, the reduction in intracranial hypertension may not be sustained. Some randomized trials have failed to demonstrate any survival or morbidity benefit of induced coma in diverse conditions such as neurosurgical operations, head trauma [4], intracranial aneurysm rupture, intracranial hemorrhage, ischemic stroke, and status epilepticus. If the patient survives, cognitive impairment may also follow recovery from the coma. [5]
About 55% of the glucose and oxygen utilisation by the brain is meant for its electrical activity and the rest for all other activities like metabolism. This is recognised by something such as an Electro encephalogram (EEG), which measures electrical activity in the brain. When barbiturates are given to a brain injured patients for Induced coma, they act by reducing the electrical activity of the brain, which in theory reduces the metabolic and oxygen demand. Once there is improvement in the patient's general condition, the barbiturates are withdrawn gradually and the patient regains consciousness.
Induced coma was used in the treatment of symptomatic rabies. See the case of Jeanna Giese.
External links
- Use of barbiturates in the control of intracranial hypertension. J Neurotrauma. 2000 Jun-Jul;17(6-7):527-30.
- Lee MW, et al. The efficacy of barbiturate coma in the management of uncontrolled intracranial hypertension following neurosurgical trauma. J Neurotrauma. 1994 Jun;11(3):325-31.
- Nordby HK, Nesbakken R. The effect of high dose barbiturate decompression after severe head injury. A controlled clinical trial. Acta Neurochir (Wien). 1984;72(3-4):157-66.
- Schwartz ML, et al. The University of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol. Can J Neurol Sci. 1984 Nov;11(4):434-40.
- Schalen W, et al. Clinical outcome and cognitive impairment in patients with severe head injuries treated with barbiturate coma. Acta Neurochir (Wien). 1992;117(3-4):153-9.